STAT3

Pages Tagged with "Stat3"

City of Hope signs licensing agreement with Scopus BioPharma Inc. to develop novel, targeted immuno-oncology gene therapy
CONTACT Letisia Marquez 626-476-7593 lemarquez@coh.org   A phase 1 clinical trial using the STAT 3 inhibitor is expected to commence at City of Hope later this year   DUARTE, Calif...